Correlation of maternal serum high-sensitive C-reactive protein levels with biochemical and clinical parameters in preeclampsia

dc.contributor.authorKumru, S
dc.contributor.authorGodekmerdan, A
dc.contributor.authorKutlu, S
dc.contributor.authorOzcan, Z
dc.date.accessioned2026-08-12T17:29:16Z
dc.date.issued2006
dc.departmentFırat Üniversitesi
dc.description.abstractObjective: To investigate the relationship between serum high sensitive C-reactive protein (hsCRP) levels and biochemical and clinical parameters in preeclampsia (PE). Study design: This cross-sectional study included 20 women with PE and 20 healthy pregnant women. They were recruited in the third trimester of pregnancy at the Firat University, Firat Medical Center, Department of Obstetric and Gynaecology in Elazig province. The standard biochemical and hematological parameters were measured by an advanced auto analyzer. Venous blood samples were collected at admission to the hospital at least 6 It before delivery for measurement of hsCRP by a high sensitive immunonephelometric method. Results: Hemoglobin, serum hsCRP, creatinine, aspartat and alanine transaminase, lactate dehydrogenase, blood urea nitrogen and urine protein excretion were higher, and serum calcium levels were lower in patients with PE compared to control group values. In the preeclampsia group, correlation analysis tests showed a strong positive correlation between serum hsCRP levels and diastolic blood pressures (r = 0.9, p = 0.05, n = 20) and urinary protein excretion (r = 0.8, p = 0.05, n = 20), and a negative correlation between serum hsCRP and weight (r = -0.6, p = 0.02, n = 20) and length (r = -0.5, p = 0.05, n = 20) of the newborns. Serum hsCRP levels were also negatively correlated with weights (r = 0.5, p = 0.02, n = 20) and lengths (r = 0.5, p = 0.05, n = 20) of the newborns in the control group. Conclusions: Serum hsCRP levels increase in women with PE. Elevated serum levels of hsCRP in preeclamptic women are correlated with clinical and biochemical parameters of PE. Determination of serum hsCRP levels may be used as a marker for the severity of PE. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
dc.identifier.doi10.1016/j.ejogrb.2005.05.007
dc.identifier.endpage167
dc.identifier.issn0301-2115
dc.identifier.issn1872-7654
dc.identifier.issue2
dc.identifier.orcid0000-0001-9257-4797
dc.identifier.pmid16054746
dc.identifier.scopus2-s2.0-31344469935
dc.identifier.scopusqualityQ2
dc.identifier.startpage164
dc.identifier.urihttps://doi.org/10.1016/j.ejogrb.2005.05.007
dc.identifier.urihttps://hdl.handle.net/11508/55640
dc.identifier.volume124
dc.identifier.wosWOS:000235348200006
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectpreeclampsia
dc.subjecteclampsia
dc.subjectHELLP syndrome
dc.subjecthsCRP
dc.titleCorrelation of maternal serum high-sensitive C-reactive protein levels with biochemical and clinical parameters in preeclampsia
dc.typeArticle

Dosyalar